|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2005
Anzahl der Publikationen: 2
2005
Lenz, G.; Dreyling, Martin; Hoster, Eva; Wörmann, Bernhard; Dührsen, U.; Metzner, B.; Eimermacher, H.; Neubauer, A.; Wandt, H.; Steinhauer, H.; Martin, S.; Heidemann, E.; Aldaoud, A.; Parwaresch, R.; Hasford, Joerg; Unterhalt, Michael und Hiddemann, Wolfgang
(2005):
Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
In: Journal of Clinical Oncology, Bd. 23, Nr. 23: S. 1984-1992
Dreyling, Martin; Lenz, G.; Hoster, Eva; Van-Hoof, A.; Gisselbrecht, C.; Schmits, R.; Metzner, B.; Truemper, L.; Reiser, M.; Steinhauer, H.; Boiron, J. M.; Boogaerts, M. A.; Aldaoud, A.; Silingardi, V.; Kluin-Nelemans, H. C.; Hasford, Joerg; Parwaresch, R.; Unterhalt, Michael und Hiddemann, Wolfgang
(2005):
Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network.
In: Blood, Bd. 105, Nr. 7: S. 2677-2684